SOURCE: DC Brands International, Inc.

November 06, 2007 13:30 ET

Major Grocer Adds Turn Left to Shelves

DENVER, CO--(Marketwire - November 6, 2007) - DC Brands International (PINKSHEETS: DCBR) is proud to announce they have received an initial purchase order from one of the country's major grocery chains. In keeping with company policy, DC Brands will release the name of the retailer after Turn Left has hit the shelves.

"This is a huge accomplishment for us," said VP of Sales Jim Randall. "We're looking at delivery the week of November 12 so the retailer can arrange shelf space. This is one lead of many we have in the works, and frankly, some are moving much faster than has been my experience in the past. Paddy Sheya, a new addition to the team, solidified this deal. Our goal is no less than 5,000 store fronts by the end of 2008 Q1, and I believe we are well on our way to achieving that goal."

About DC Brands International:

DC Brands International, a publicly traded company under the ticker symbol (PINKSHEETS: DCBR), specializes in and manufactures unique energy drink brands. Established in 1998, DC Brands went public in 2005, and the company's first product, Dickens Energy Cider, launched in 2002 after a lengthy process in developing its distinctive flavor and packaging. Following the success of Dickens Energy Cider, the company chose to expand its product line with a beverage that filled the substantial NASCAR niche. With more than 75 million loyal fans, the NASCAR demographic presented an attractive opportunity to become one of the few racecar-themed energy drinks in the marketplace. Following much due diligence, research and testing, Turn Left Energy Drink recently came to fruition.

For more information on DC Brands International, visit their website at www.TurnLeftEnergy.com and DickensEnergyCider.com.

Note: Except for the historical information contained herein, this news release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third-party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by DC Brands International with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of DC Brands International as of the date of this release. DC Brands International and its managers and agents undertake no obligation to publicly update any forward-looking statements.

Contact Information